Indian pharmaceutical companies entering the U.S. market often underestimate the impact of poor tax planning on long-term profitability. From transfer pricing challenges to entity structuring and state-level taxes, small missteps can erode margins quickly. A well-defined U.S. tax strategy helps Indian pharma exporters protect profits, stay compliant, and scale sustainably in a highly ... https://indamadvisors.com/how-lack-of-us-tax-planning-reduces-profit-margins-for-indian-pharmaceutical/